Skip to main content

GSA Logo High Res No Background (1) (2)-1

 

    Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

    Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial

    Click HERE to view the article on PubMed.gov.

    The Gorlin Syndrome Alliance and NORD Launch Natural History Study for Gorlin Syndrome

    Click HERE to read the NORD press release. Click HERE to view information on the Gorlin Syndrome Alliance Patient Registry ...

    Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivity analysis

    Click here to read the article on the BMC Cancer website.

    Treatment of Advanced Basal Cell Carcinoma with Hedgehog Pathway Inhibitors: A Multidisciplinary Expert Meeting

    Click here to view the article on PubMed.

    Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis

    Click here to read the article on PubMed.

    Proposed criteria for nevoid basal cell carcinoma syndrome in children assessed using statistical optimization

    Click HERE to view the article on PubMed.gov.

    CODY Trial: Clinical Trial of a topical gel for the prevention of basal cell carcinomas in adults with Gorlin syndrome.

    [fusion_builder_container type="flex" hundred_percent="no" hundred_percent_height="no" min_height_medium="" ...

    Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma

    Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and ...

    Register for Exclusive GSA Discounts!

    [fusion_builder_container type="flex" hundred_percent="no" hundred_percent_height="no" min_height_medium="" ...

    Cutaneous Keratocyst With D2-40 Immunoreactivity in Basal Cell Nevus Syndrome

    [fusion_builder_container type="flex" hundred_percent="no" hundred_percent_height="no" min_height_medium="" ...